1. Reversible phospho‐Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. (April 2014) Authors: Deng, Y.‐R.; Yoshida, K.; Jin, Q. L.; Murata, M.; Yamaguchi, T.; Tsuneyama, K.; Moritoki, Y.; Niu, J. Q.; Matsuzaki, K.; Lian, Z.‐X. Journal: Clinical and experimental immunology Issue: Volume 176:Number 1(2014:Apr.) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial. Issue 2 (22nd September 2014) Authors: Hou, J. L.; Gao, Z. L.; Xie, Q.; Zhang, J. M.; Sheng, J. F.; Cheng, J.; Chen, C. W.; Mao, Q.; Zhao, W.; Ren, H.; Tan, D. M.; Niu, J. Q.; Chen, S. J.; Pan, C.; Tang, H.; Wang, H.; Mao, Y. M.; Jia, J. D.; Ning, Q.; Xu, M. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 2(2015) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗